Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06444542 · ClinicalTrials.gov registry record
Understanding Patient Preference on Colorectal Cancer Screening Options-PSU
A clinical trial of Colo-rectal Cancer, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 297
- Enrollment target
- 1
- Study location
NCT06444542 is a study of Colo-rectal Cancer that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 297 participants, below the 2,780-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06444542, a study of Colo-rectal Cancer, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
- 1
- Study location
Study Summary
There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening
Conditions Studied
Interventions
- BEHAVIORAL Guardant Shield
Study Locations (1)
Pennsylvania
- Penn State College of Medicine - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2025-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06444542
The ClinicalTrials.gov registry entry for NCT06444542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,780-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colo-rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Guardant Shield is the first listed.
NCT06444542 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06444542 about?
NCT06444542 is a clinical study titled "Understanding Patient Preference on Colorectal Cancer Screening Options-PSU". There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve ...
What is the current status of trial NCT06444542?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2024-09-16. Estimated completion is 2025-12-18.
What conditions does trial NCT06444542 study?
This clinical trial studies the following conditions: Colo-rectal Cancer.
What interventions are being tested in trial NCT06444542?
The interventions under investigation include: Guardant Shield (BEHAVIORAL).
Who is sponsoring clinical trial NCT06444542?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06444542 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colo-rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
RECRUITING · NA
-
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
RECRUITING · Phase 2
-
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
RECRUITING · NA
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.